Pediatric Blood & Cancer

Article	Citations
Dasatinib‐induced pulmonary arterial hypertension in pediatric acute lymphoblastic leukemia with Philadelphia chromosome: A report of two cases	92
Isotretinoin‐induced psychosis in a child on treatment for high‐risk neuroblastoma	68
A novel central nervous system embryonal tumor successfully treated with multi‐modal therapy highlights limitation of methylation‐based tumor classification	60
Role of regional anesthesia in patients with acute sickle cell pain: A scoping review	47
Outcomes following proton therapy for pediatric esthesioneuroblastoma	46
Comment on: Role of regional anesthesia in patients with acute sickle cell pain: A scoping review	44
Psychosocial functioning of caregivers of pediatric brain tumor survivors	42
Prediction of family‐centered care on the unmet care needs of parents of pediatric oncology patients and their psychosocial problems	41
Massage therapy for children, adolescents, and young adults: Clinical delivery and effectiveness in hematology and oncology	36
Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors	35
Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol	35
Ocular survival after intra‐arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution	33
Imaging of pediatric brain tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper	33
Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina	30
Abstracts from the 40th Annual Meeting of the Histiocyte Society Held Virtually and In Person in Goa, India from November 6‐9, 2024	30
NUP214::ABL1: A Ph‐like fusion found in a pediatric acute myeloid leukemia patient with normal karyotype	29
Issue Information	29
Comment on: Severe β‐thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia—The deceivingly normal mean corpuscular volume and hemoglobin electrophoresis in dominantly inherited β‐thalas	28
Clinical implication of residual MIBG‐positive disease in the follow‐up of high‐risk neuroblastoma treated with tandem high‐dose chemotherapy and autologous stem cell transplantation	28
When you just cannot fit neatly into a box—The quagmire of practicing paediatric oncology in low‐ and middle‐income countries	27
Exploring the role of pain on physical activity among youth with acute lymphoblastic leukemia using the biopsychosocial model	27
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high‐dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma—Safety and outcomes	27
The medical and functional burden of surviving childhood ependymoma: A population‐based study in Ontario, Canada	26
A modern approach to multiple pulmonary resections in children with recurrent metastatic pulmonary disease	25
Venous thromboembolism in transgender and gender non‐binary youth is rare and occurs in the setting of secondary risk factors: A retrospective cohort study	25

Treatments affecting splenic function as a risk factor for valvular heart disease in Childhood Cancer Survivors: A DCCSS‐LATER study	24
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome	24
Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities	24
The Performance of the Australian–UK–Swiss Clinical Decision Rule for Febrile Neutropenia in Children and Young Adults With Bone and Soft Tissue Sarcomas	23
The ghost of parvovirus past: Idiopathic pure red cell aplasia responding to IVIG following resolved perinatal parvovirus B19 infection	23
Musculoskeletal misdiagnoses in pediatric patients with spinal tumors	22
Re‐examining a strong recommendation based on low‐quality evidence in acute chest syndrome	22
Ten‐year outcome in disseminated juvenile xanthogranuloma with central nervous system involvement: A case report	22
Meditation reduces brain activity in the default mode network in children with active cancer and survivors	21
Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic‐hypothalamic low‐grade glioma	21
Comment on: Effects of hydroxyurea on brain function in children with sickle cell anemia	20
The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes	20
Predicting neurocognitive function in pediatric brain tumor early survivorship: The neurological predictor scale and the incremental validity of tumor size	20
Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS‐PNET in Oslo 2005–2017	19
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	19
An acute lymphoblastic leukemia cell‐based preclinical assay revealed functional differences between commercial brands of L‐asparaginase administered in Colombia	19
Identification of RCC1–LCK as a novel fusion gene in pediatric erythroid sarcoma	19
Like apples, rhabdomyosarcomas come in so many kinds	19
Severe eosinophilia induced by influenza A (H1N1) virus: An unusual case	19
Posttransplant gilteritinib maintenance therapy for pediatric acute myeloid leukemia with myelodysplasia‐related changes with FLT3‐internal tandem duplication	19
Clinical trials in desmoid‐type fibromatosis in children and adults: A systematic review	19
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma	19
Multimodality treatment for recurrent neuroblastoma in the central nervous system	19
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	18
Rates and predictors of visits to primary care physicians during and after treatment of childhood acute lymphoblastic leukemia: A population‐based cohort study	18
Issue Information	18
Hyphaema unmasking the underlying haemophilia‐A	18
A tangled web: Dual diagnosis of hereditary hemorrhagic telangiectasia and familial cerebral cavernous malformation	18
The expense of sending cerebrospinal fluid for analysis on all lumbar punctures in pediatric acute lymphoblastic leukemia patients	18
Comment on: Pulmonary embolism in pediatric and adolescent patients with COVID‐19 infection during the SARS‐CoV‐2 delta wave	18
Defining vascular anomaly phenotypes in children based on a systematic literature search: A critical step in developing a single severity score for interventional clinical trials	18
Do no harm: Distinguishing between rebound thymic hyperplasia and Hodgkin lymphoma relapse in children	17
High‐dose methotrexate therapy for a child with B‐cell precursor acute lymphoblastic leukemia and congenital solitary kidney	17
SIOP ABSTRACTS	17
Vacuolization of large myeloid lineage and absence of erythroblast and megakaryocyte: Clues to the diagnosis of hereditary transcobalamin II deficiency	17
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	17
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant	17
Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance?	16
Imaging of pediatric pulmonary tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper	16
Role of anticoagulation in the management of tumor thrombus: A 10‐year single‐center experience	16
Imaging of pediatric testicular tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper	16
Psychosocial outcomes and quality of life among school‐age survivors of retinoblastoma	16
Imaging of pediatric cardiac tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper	16
The grander challenge of pediatric oncology: Disparities in access to care	15
Malignancy in disguise: ALK‐positive anaplastic large cell lymphoma with refractory hyperinflammation and CNS involvement	15
Unfolding parental knowledge, attitudes, and beliefs toward palliative care for children with cancer	15
Does granulocyte transfusion help pediatric cancer patients with sepsis?	15
Unusual relapse of low hypodiploid acute lymphoblastic leukaemia in a family with Li‐Fraumeni syndrome	15
Systemic Epstein–Barr virus‐positive T‐cell lymphoma of childhood treated with the ICE regimen and allogeneic hematopoietic stem‐cell transplantation	15
Novel case of ELANE‐related severe congenital neutropenia with initially normal bone marrow	15

Cardiac function in pediatric Ewing sarcoma during and after treatment: A longitudinal study	15
Comment on: Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia	14
Comprehensive genomic profiling suggested multifocal development of retinoblastoma in a single eye	14
Supportive care in paediatric oncology during the pandemic: Lessons from a nationwide survey in India	14
Molecular characterization of metachronous atypical teratoid rhabdoid tumors occurring in a young man 15 years apart	14
Acute lymphoblastic leukemia with pancreatic infiltration: Atypical presentation of a common disease in a 3‐month‐old infant: A case report	14
Tumor region associated with specific processing speed outcomes	14
	14
	14
IKZF1::CIITA, a novel fusion transcript in a case of relapsed B‐cell acute lymphoblastic leukemia	14
How we approach transfusions in a patient with high risk of alloimmunization from McLeod phenotype	14
Cabozantinib as a successful salvage therapy in chemo‐refractory Ewing sarcoma	13
Successful isavuconazole salvage therapy for cerebral mucormycosis in a child with relapsed leukemia: A light in the dark tunnel	13
Transient and fully reversible changes in laboratory parameters and modifications of the cytokine profile during blinatumomab treatment in children with relapsed or refractory B‐cell acute lymphoblast	13
Congenital embryonal tumor of the central nervous system with a rapidly fatal outcome in the neonatal intensive care unit	13
	13
Issue Information	13
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor	13
Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment	13
Novel ribosomal protein L26 variant and modeling in a patient with Diamond–Blackfan anemia: Case report	13
Quality of life in children and adolescents after treatment for acute lymphoblastic leukemia according to the NOPHO ALL2008 protocol	12
Luspatercept for non‐deletional hemoglobin H disease	12
Examining community‐level social vulnerability and emergency department use for people living with sickle cell disease in Michigan	12
Poor disease‐specific survival in Black pediatric patients diagnosed with Burkitt lymphoma: An analysis of the Surveillance, Epidemiology, and End Results database	12
IKZF1PLUS alterations contribute to outcome disparities in Hispanic/Latino children with B‐lymphoblastic leukemia	12
Juvenile xanthogranuloma manifesting with LCH‐associated neurodegenerative disease‐like radiological findings	12
Late‐onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma	12
Trends in analgesia‐sedation of pediatric patients receiving I‐131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database	12
Reliability, usability, and efficiency of video versus print instructions to teach parents a procedural task: A cross‐sectional study	12
KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up	12
The Australian New Zealand Consortium in Children, Adolescents, and Young Adults Oncofertility action plan	12
Status of articles on cancer and religious coping from past to present	12
Concomitant sickle cell disease and systemic lupus erythematosus: A single‐center case series	12
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes	12
Issue Information	12
Healthcare utilization disparities among children with high‐risk neuroblastoma treated on Children's Oncology Group clinical trials	12
Discovering needs for palliative care in children with cancer in Indonesia	12
Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population‐based study	12
Psychosocial risk and health care utilization in pediatric sickle cell disease	11
Comment on: Brentuximab vedotin‐related neuropathy in a patient with Gilbert syndrome: Do mutations of UGT1A1 gene affect brentuximab toxicity?	11
Infantile fibrosarcoma: Is spontaneous regression possible?	11
Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high‐risk neuroblastoma clinical trial	11
Abstracts from the 37th Annual Meeting of the Histiocyte Society Held Virtually on October 11‐12, 2021	11
Children's Oncology Group's 2023 blueprint for research: Pharmacy	11
Mental health and health‐related quality of life in preschool‐aged childhood cancer survivors. Results of the prospective cohort study ikidS‐OEVA	11
Retiring as a pediatric hematologist‐oncologist during the COVID‐19 pandemic	11
Learning to listen: A plea to our profession	11
Diagnostic challenge in a case of ambiguous lineage acute leukemia with PICALM::MLLT10 rearrangement	11
Issue Information	11
Abstracts for PBC Volume 68, Supplement 6	11
Comment on: Parents’ responses to prognostic disclosure at diagnosis of a child with a high‐risk brain tumor: Analysis of clinician–parent interactions and implications for clinical practice. The role	11
Children's Oncology Group's 2023 blueprint for research: Young investigators	11
Perception and management of cancer predisposition in pediatric cancer centers: A European‐wide questionnaire‐based survey	11
Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics	11
Issue Information	11
Broaching goals‐of‐care conversations in advancing pediatric cancer	11
High burden of clinically significant adverse events associated with contemporary therapy for pediatric T‐cell acute lymphoblastic leukemia/lymphoma	11
Issue Information	11
Erythrocytosis as the initial presentation of pediatric adrenocortical carcinoma: A case report and review of the literature	11
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Reg	11
Children's Oncology Group's 2023 blueprint for research: Epidemiology	11
Locoregional failure after postoperative flank irradiation for nephroblastoma: Results from the French cohort of the SIOP‐2001 trial	11
A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual dise	10
Need for pneumococcal revaccination after blinatumomab therapy: A case report	10
Pediatric Philadelphia chromosome‐positive B‐lymphoblastic lymphoma with testicular relapse: A case report	10
	10
Vincristine/irinotecan/temsirolimus upfront window treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee	10
Changes in the developmental status of preschoolers with sickle cell disease	10
High‐frequency temperature monitoring at home using a wearable device: A case series of early fever detection and antibiotic administration for febrile neutropenia with bacteremia	10
Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations	10
Cost‐effectiveness analysis of recombinant factor IX Fc fusion protein compared with recombinant factor IX for the treatment of moderate–severe to severe hemophilia B in China	10
Targeting plasma cells with daratumumab aids in the treatment of post‐transplant autoimmune‐like hepatitis	10
Idiopathic multicentric Castleman disease in an adolescent diagnosed following COVID‐19 infection	10
Childhood Kaposi sarcoma related to hypomorphic severe combined immunodeficiency caused by a novel CORO1A mutation	10
Drug‐induced panniculitis in a child with acute lymphoblastic leukemia	10
Comment on: Discrepancies between F‐18‐FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis	10
Neonatal intestinal obstruction in Hoyeraal–Hreidarsson syndrome with novel RTEL1 variants	10
The predictive performance and impact of pediatric early warning systems in hospitalized pediatric oncology patients—A systematic review	10
Guideline for treating relapsed or refractory myeloid leukemia in children with Down syndrome	10
Survival effect of complete surgical resection of the primary tumor in patients with metastatic, high‐risk neuroblastoma in a large Canadian cohort	10

A phase 1 study of mebendazole with bevacizumab and irinotecan in high‐grade gliomas	10
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group	10
Comment on : A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous locations and molecular subgrou	10
Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study	10
The Ukrainian children emergency: How the Pediatric Oncology Unit of Turin supports cancer patients and their families who have escaped war	10
Dasatinib‐therapy induced sustained remission in a child with refractory TCF7‐SPI1 T‐cell acute lymphoblastic leukemia	10
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors	10
Single‐agent rituximab for treatment of multifocal and multiple relapsed pulmonary inflammatory myofibroblastic tumor in an adolescent patient	10
Rare case of Rosai–Dorfman disease linked to a mixed malignant tumor with germ cell and central type primitive neuroectodermal components	9
Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta‐analysis	9
	9
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate‐risk Hodgkin lymphoma treated with chemo‐radiation therapy: FDG‐PET parameter analysis in a subgroup f	9
Musculoskeletal impairments in children receiving intensive therapy for acute leukemia or undergoing hematopoietic stem cell transplant: A report from the Children's Oncology Group	9
System's failure: Poor adherence to guidelines for children with sickle cell disease	9
Bloom where you are planted: Hemangioma or malignancy?	9
Early thrombotic and hemorrhagic complications associated with a risk‐adjusted postoperative anticoagulation protocol after pediatric liver transplantation	9
Clinical and transcriptomic characteristics of a novel SMARCD2 mutation that disrupts neutrophil maturation and function	9
Appropriateness of 14‐year cutoff in pediatric differentiated thyroid cancer: Comparison of clinical characteristics and long‐term outcomes in 14 years and younger and 15–18 years age groups	9
Assessing coagulopathy and endothelial dysfunction in pediatric venous malformation: A thromboelastometry and syndecan‐1 study	9
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	9
The role of ethicists in pediatric hematology/oncology: Current status and future needs	9
Megaloblastic anemia and benign proteinuria: Clues to the diagnosis of Imerslund–Gräsbeck syndrome	9
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213	9
	9
Interprofessional spiritual care education in pediatric hematology‐oncology: A pilot study	9
Aberrant expression of TFE3 in granular cell tumor: Four cases in pediatrics	9
Impact of hospitalization for vaso‐occlusive crisis on health‐related quality of life in children with sickle cell disease	9
Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden: A population‐based cohort study	9
	9
Busulfan, fludarabine, and melphalan are effective conditioning for pediatric and young adult patients with myeloid malignancies underdoing matched sibling or alternative donor transplantation	9
Issue Information	9
Severe rituximab‐induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura	9
	9
Anti‐CD19 CAR T cells administration was feasible in a child with primary hepatitis B infection	9
Bone health in long‐term survivors of pediatric acute lymphoblastic leukemia. An assessment by peripheral quantitative computed tomography	9
Choriocarcinoma in neonates and infants: A severe but curable disease	9
Disseminated fungal disease caused by Magnusiomyces clavatus in a pediatric cancer patient: Case report and review of the literature	9
Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database	9
	9
Rare cell‐in‐cell phenomenon in a pediatric malignant rhabdoid tumor	9
Role of non‐chromosomal birth defects on the risk of developing childhood Hodgkin lymphoma: A Children's Oncology Group study	9
	9
	9
Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper	9
Successful enteral administration of crushed posaconazole delayed‐release tablets in children	9
Addressing adherence to guidelines on prevention of acute chemotherapy‐induced nausea and vomiting in pediatric patients	9
Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report	9
Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome	9
How we approach complex vascular anomalies and overgrowth syndromes	9
Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high‐dose methotrexate therapy in open‐label trials	9
Secondary impacts of constipation in acute lymphoblastic leukemia in U.S. children's hospitals	9
Comment on: Diagnosis and treatment interval are not associated with survival in rhabdomyosarcoma: A cancer in young people in Canada study	9
E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not‐amplified neuroblastoma: Results of in silico analysis of 786 samples	9
A novel SLC4A1 mutation in a child with hereditary spherocytosis and distal renal tubular acidosis	9
How we approach localized vascular anomalies	9
Exploring the impact of anterior chest wall scars from implantable venous ports in adolescent survivors of cancer	9
Synchronous rare tumors in a pediatric patient with a de novo cancer predisposition syndrome	8
Factor activity levels and bleeding scores in pediatric hemophilia carriers enrolled in the ATHNdataset	8
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know	8
He knew more than we wanted him to know: Parent perceptions about their children's sense of pediatric cancer‐related financial problems	8
The relationship between nutrition, gut dysbiosis, and pediatric sickle cell pain outcomes: A pilot study	8
Successful cord blood transplantation using reduced intensity conditioning in a 5‐month‐old patient with IL‐10RA deficiency	8
Rim‐type indocyanine green fluorescence pattern in a child with undifferentiated embryonal sarcoma of the liver treated with navigation surgery	8
Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)	8
Concurrent rhabdomyosarcoma and neuroblastoma in an infant with Costello syndrome	8
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	8
Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study	8
	8
ELANE neutropenia and solid tumors: Four cases from the French severe chronic neutropenia registry	8
Clinical features and imaging manifestations of retinoblastoma with hepatic metastasis	8
Impact of COVID‐19 pandemic on delivery of pediatric radiotherapy: A critical review	8
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research	8
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia	8
Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332	8
Hematopoietic cell transplantation for hematological malignancies in Bloom syndrome	8
Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial doppler ultrasonography	8
Abstracts for PBC Volume 69, Supplement 4	8
Virtual support groups in pediatric hematology/oncology during COVID‐19: Lessons learned from the SickKids experience	8
Hypofractionated re‐irradiation for diffuse intrinsic pontine glioma	8
Issue Information	8
SARS‐CoV‐2 as a mimicker of pulmonary metastasis in osteosarcoma	8
Physiological stress reactivity in pediatric cancer survivors treated with chemotherapy	8
Issue Information	8
Comment on: Treatment‐induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider	8
Eye‐related quality of life and activities of daily living in pediatric retinoblastoma patients: A single‐center, non‐controlled, cross‐sectional analysis	8
The unfulfilled promise from a forgotten child	8
Adolescent‐ and adult‐onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020	8
Combination therapy for unresectable primitive myxoid mesenchymal tumor of infancy: A story of cure	8
Health‐related quality of life in infants, toddlers and young children with sickle cell disease	8
	8
Healthcare utilization and cost barriers among U.S. childhood cancer survivors	8
The influence of child pain catastrophizing and parent behavior on health‐related quality of life in pediatric sickle cell disease	8
Mesothelioma with ALK gene mutations in two pediatric patients: Clinical course and outcome	7
A case of high‐risk neuroblastoma in a child with CLOVES syndrome	7
Lung relapse pattern in children with metastatic Wilms tumor	7